Hints and tips:
...It was the relative affordability of the Loire region — €32,300 per hectare on average in 2019 — that caught the eye of Oslo-based entrepreneur Andrew Marshall....
...Roy Baynes, chief medical officer at Merck, said Keytruda was the “most broad spectrum anti-cancer drug ever”....
...In an interview, Roy Baynes, head of global clinical development at Merck, said the company was working with Incyte on studies across five different tumour types....
...The question of how to promote strong university-industry links is under study in an investigation led by Andrew Witty, chief executive of GlaxoSmithKline (GSK), the pharmaceutical group....
...“Some of these technologies are going to come good,” says Mr Baynes....
...Andrew Swinand, president of Starcom MediaVest, said the tone of his clients’ messages had changed since the recession bit....
International Edition